Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anterior ischemic optic neuropathy

S S Hayreh1

  • 1Department of Ophthalmology, University Hospitals & Clinics, Iowa City, IA 52242-1091, USA.

Clinical Neuroscience (New York, N.Y.)
|January 1, 1997
PubMed
Summary

Anterior ischemic optic neuropathy (AION) is a vision-threatening condition affecting the optic nerve head. Prompt diagnosis and corticosteroid treatment are crucial for arteritic AION to prevent blindness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploding head syndrome: new observations.

European journal of neurology·2020
Same author

Comment on 'The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary'.

Eye (London, England)·2016
Same author

Orbital vascular anatomy.

Eye (London, England)·2006
Same author

Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.

Eye (London, England)·2004
Same author

Count and size of macular drusen correlated with the parafoveal annular reflex.

The British journal of ophthalmology·2004
Same author

Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.

European journal of ophthalmology·2004

Area of Science:

  • Ophthalmology
  • Neurology
  • Vascular Medicine

Background:

  • Anterior ischemic optic neuropathy (AION) is a leading cause of vision loss in middle-aged and elderly individuals.
  • It results from acute ischemia of the optic nerve head, potentially leading to bilateral vision impairment.

Purpose of the Study:

  • To elucidate the pathogenesis, causes, clinical features, and management of AION.
  • To differentiate between arteritic and nonarteritic AION and outline appropriate treatment strategies.

Main Methods:

  • Review of scientific literature on AION.
  • Discussion of clinical parameters for differentiating AION subtypes.
  • Outline of management protocols for AION.

Main Results:

  • AION presents in two main forms: arteritic AION (AAION) due to giant cell arteritis and nonarteritic AION (NAION) from other causes.
  • AAION is an ophthalmic emergency requiring immediate systemic corticosteroid treatment to prevent irreversible blindness.

Conclusions:

  • Understanding AION's pathophysiology is key to its management.
  • Timely differentiation and treatment of AAION with corticosteroids can preserve vision and prevent bilateral blindness.

Related Experiment Videos